Opioids: what can be done about long-term prescribing?
Recent data show the number of patients taking long-term opioids has increased significantly, suggesting there is still progress to make in this area of prescribing.…
News
See all-
Pharmacy negotiators ‘disappointed’ as fee for autumn 2022 COVID-19 boosters is cut
-
NHS saves £1.2bn in drive to switch to cheaper versions of medicines
-
Candidates affected by registration assessment delays will be added to provisional register
-
NHS staff on long-term sick leave from COVID-19 will no longer receive extended full pay
-
Pharmacists advised to complete training course before certifying fit notes
Sign in now if you’re an RPS member or subscriber.
Become a member of the RPS or subscribe to gain unlimited access.
News from Wales
NHS staff on long-term sick leave from COVID-19 will no longer receive extended full pay
RPS publishes first-ever blueprint for advanced pharmacist core practice
Always say ‘sorry’ when things go wrong, advises pharmacy regulator
Pharmacies able to apply for environmentally sustainable awards
Community pharmacies will be unable to issue NHS fit notes under new legislation, government confirms
Pharmacists to be given legal right to certify fit notes from July 2022
Almost 15% of MPharm students leave course after first year in 2020/2021
News from Scotland
RPS publishes first-ever blueprint for advanced pharmacist core practice
Always say ‘sorry’ when things go wrong, advises pharmacy regulator
Most GP practices have ‘partial access’ to pharmacotherapy service in Scotland
Community pharmacies will be unable to issue NHS fit notes under new legislation, government confirms
RPS vision for pharmacy by 2030 will ‘enhance patient care’, says MSP
Pharmacists to be given legal right to certify fit notes from July 2022
First routine clopidogrel genotype testing introduced at health board
Learning & CPD
Medication restrictions for patients receiving CAR-T therapy
Educational supervision, assessment and feedback for pharmacists
Renal cancer: management
Supported content
Glucagon-like peptide-1 analogues in adults with type 2 diabetes mellitus for glycaemic control
Familial hypercholesterolaemia: identification and management
DPYD genetic testing and the future of pharmacogenomic testing in routine care
Management of Parkinson’s disease
Gastrointestinal system diseases
See all-
Inflammatory bowel disease: symptoms and diagnosis
-
Inflammatory bowel disease: treatment and management
-
FDA approves two new drugs for irritable bowel syndrome
-
Antihistamine reduces pain in irritable bowel syndrome
-
Optimising therapy for inflammatory bowel disease
-
Management of patients with inflammatory bowel disease: current and future treatments
-
Management of acute upper gastrointestinal bleeding
-
Understanding irritable bowel syndrome: bugs, brains and leaky barriers
Want to see content related to your country or pharmacy sector on your homepage? Visit your preference centre to update your interests and help us improve your digital experience.
Newly registered?
Find our dedicated career advice and resources, clinical CPD and professional skills content here.
Research
See all-
3D printing of pharmaceuticals and the role of pharmacy
-
Addressing drug–microbiome interactions: the role of healthcare professionals
-
Direct oral anticoagulants in the treatment of portal vein thrombosis: a therapeutic review
-
How community pharmacy pharmacogenomics testing services around the world can inform their design and delivery in the UK
-
Racial and ethnic disparities in mental health care
-
Building on hepatitis C testing: the potential to identify alcohol-related liver disease through community pharmacy